Cargando…
Interactions of SARS-CoV-2 envelope protein with amilorides correlate with antiviral activity
SARS-CoV-2 is the novel coronavirus that is the causative agent of COVID-19, a sometimes-lethal respiratory infection responsible for a world-wide pandemic. The envelope (E) protein, one of four structural proteins encoded in the viral genome, is a 75-residue integral membrane protein whose transmem...
Autores principales: | Park, Sang Ho, Siddiqi, Haley, Castro, Daniela V., De Angelis, Anna A., Oom, Aaron L., Stoneham, Charlotte A., Lewinski, Mary K., Clark, Alex E., Croker, Ben A., Carlin, Aaron F., Guatelli, John, Opella, Stanley J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8184013/ https://www.ncbi.nlm.nih.gov/pubmed/34003853 http://dx.doi.org/10.1371/journal.ppat.1009519 |
Ejemplares similares
-
Comparative Analysis of T-Cell Spatial Proteomics and the Influence of HIV Expression
por: Oom, Aaron L., et al.
Publicado: (2022) -
Hexamethylene amiloride binds the SARS‐CoV‐2 envelope protein at the protein–lipid interface
por: Somberg, Noah H., et al.
Publicado: (2023) -
Antiviral effect of amiloride on replication of foot and mouth disease virus in cell culture
por: Gong, Mei-jiao, et al.
Publicado: (2019) -
Antifungal activity of 6-substituted amiloride and hexamethylene amiloride (HMA) analogs
por: Vu, Kiem, et al.
Publicado: (2023) -
Amiloride: A review
por: Sun, Qianhui, et al.
Publicado: (2020)